Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia


Sevinc A., ÖZKAN M., Ozet A., DANE F., Oksuzoglu B., Isikdogan A., ...More

ONCOTARGETS AND THERAPY, vol.11, pp.419-426, 2018 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 11
  • Publication Date: 2018
  • Doi Number: 10.2147/ott.s106342
  • Title of Journal : ONCOTARGETS AND THERAPY
  • Page Numbers: pp.419-426

Abstract

Background: We studied the comparative effectiveness of biosimilar filgrastim vs original filgrastim in patients with chemotherapy-induced neutropenia.